Metric Finance
LearnFAQ
LearnFAQ

Learn / ODTX

NASDAQ: ODTX

Odyssey Therapeutics (ODTX) stock, explained like you're 5

Odyssey Therapeutics trades on the Nasdaq under the ticker ODTX. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 913 million dollars.

Ticker
ODTX
Exchange
Nasdaq
Sector
Healthcare
Industry
Biological Products (No Diagnostic Substances)
Size
Small cap, about 913 million dollars

Is Odyssey Therapeutics a small, medium or large cap company?

No. Odyssey Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 913 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Odyssey Therapeutics makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ODTX stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Odyssey Therapeutics (Nasdaq:ODTX) Stock Analysis (Simply Wall Street)
  • Top Odyssey Therapeutics (ODTX) Competitors 2026 (MarketBeat)
  • Odyssey Therapeutics to Present Design of Phase 2a Study Evaluating OD 001 in Combination with Vedolizumab at ACG 2026 (Yahoo Finance)
  • A study will test two ulcerative colitis treatments together in up to 146 people (Stock Titan)
  • UBS initiates Odyssey Therapeutics stock with buy rating on IBD drug (Investing.com Nigeria)

Follow ODTX in your daily brief

Each trading day at 5 PM ET we post what happened to Odyssey Therapeutics and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow ODTX

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Odyssey Therapeutics stock

What does Odyssey Therapeutics do?

Odyssey Therapeutics trades on the Nasdaq under the ticker ODTX. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 913 million dollars.

What is the ticker symbol for Odyssey Therapeutics?

Odyssey Therapeutics trades under the ticker ODTX on the Nasdaq.

What is Odyssey Therapeutics's market cap?

Odyssey Therapeutics is a small cap stock with a market cap of about 913 million dollars.

How does Odyssey Therapeutics make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ODTX stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ODTX stock every day?

Add ODTX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow ODTX daily

A free brief on Odyssey Therapeutics and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ARGX · Argenx SE
  • RVMD · Revolution Medicines
  • BNTX · BioNTech SE
  • EXEL · Exelixis

Similar stocks

  • ARGXArgenx SE
  • RVMDRevolution Medicines
  • BNTXBioNTech SE
  • EXELExelixis

Compare ODTX: ODTX vs ARGX, ODTX vs RVMD, ODTX vs BNTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed